NCT00246402View on ClinicalTrials.gov

Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

August 31, 2006

Conditions
Insulin ResistanceCardiovascular DiseasesHeart DiseasesHIV InfectionsHypertriglyceridemiaHyperlipidemia
Interventions
DRUG

Acipimox

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00246402 - Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV | Biotech Hunter | Biotech Hunter